Gritstone Oncology, Inc.
(NASDAQ : GRTS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -1.91%159.660.7%$1363.45m
PFEPfizer Inc. -0.52%33.650.9%$1235.79m
BMYBristol-Myers Squibb Co. -0.83%61.591.0%$869.38m
MRKMerck & Co., Inc. -2.23%72.960.7%$817.25m
ABBVAbbVie, Inc. 0.77%108.161.9%$814.78m
LLYEli Lilly & Co. 0.93%205.711.1%$789.42m
AZNAstraZeneca Plc -0.80%48.521.2%$515.96m
GSKGlaxoSmithKline Plc -2.07%33.670.2%$264.82m
NVSNovartis AG -0.66%86.140.2%$189.47m
SNYSanofi 0.43%46.000.2%$169.17m
VTRSViatris, Inc. -0.57%14.970.0%$143.54m
VERUVeru, Inc. -2.73%13.890.0%$115.71m
CVACCureVac NV 1.96%94.800.0%$108.35m
VYNEVYNE Therapeutics, Inc. -4.94%7.500.0%$95.25m
NVONovo Nordisk A/S -1.27%71.420.1%$91.84m

Company Profile

Gritstone Oncology, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA.